# Sequential Versus Simultaneous Use of Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer (MBC)

> **NCT00629148** · PHASE2 · COMPLETED · sponsor: **Fudan University** · enrollment: 60 (actual)

## Conditions studied

- Breast Cancer
- Metastasis, Neoplasm

## Interventions

- **DRUG:** Vinorelbine and Capecitabine
- **DRUG:** Vinorelbine and Capecitabine

## Key facts

- **NCT ID:** NCT00629148
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2009-08
- **Final completion:** 2010-12
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2011-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00629148

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00629148, "Sequential Versus Simultaneous Use of Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer (MBC)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00629148. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*